Below is a roundup of fitness news.
Activist Icahn prepares a second board challenge at Illumina -letter
Activist investor Carl Icahn said Monday he plans to oust Illumina’s directors, laying the groundwork for a second challenge to the genetic sequencing company’s board of directors months after shareholders chose one of its candidates for the director’s seat. Icahn revealed his plans without giving the main points in a letter. to other shareholders less than 24 hours after Illumina announced it would sell blood test maker Grail.
Lawsuits Claiming Tylenol Causes Autism Have No Scientific Basis, Judge Says
A ruling barred qualified witnesses from attesting that Johnson’s painkiller, Tylenol, was derived from
WHO says JN.1 COVID strain a ‘variant of interest’, poses low risk
The World Health Organization (WHO) on Tuesday classified the JN. 1 coronavirus strain as a “variant of interest” and said existing evidence shows the public health threat is low from the strain. At least two experts told Reuters that while the strain can evade the immune formula and spread more easily than other variants currently circulating, it has shown no symptoms of more severe disease.
South Korea: 8 Outbreaks of H5N6 Avian Influenza on Farms
South Korea has reported 8 cases of H5N6 bird flu on farms, leading to the culling of more than 500,000 poultry, the World Organisation for Animal Health (WOAH) reported on Tuesday.
Outbreaks of highly pathogenic avian influenza, known as bird flu, were detected between Dec. 5 and Dec. 11 in villages in the west of the country, WOAH said in a report posted on its website that collects data from the South Korean government.
Juul Seeks U. S. Approval U. S. Centers for New Age-Restricted Menthol Capsules
Juul Labs said Tuesday that the U. S. approval will be a step forward. The U. S. Customs and Drug Administration for its new menthol-flavored pods, which require verification of the user’s age, for use with its e-cigarette device is under review by regulators. Juul’s e-cigarettes were briefly banned in the U. S. U. S. Census Enforcement in June 2022 after the U. S. Food and Drug Administration (FDA) announced that the U. S. Food and Drug Administration (FDA)The U. S. Food and Drug Administration (FDA) concluded that the company had failed to demonstrate that the sale of its products would be suitable for public fitness. Following an appeal, the fitness regulator suspended the ban and agreed to an additional review of Juul’s marketing. request.
Europe revokes marketing authorisation for Biogen’s generic MS drug
Biogen Inc said on Tuesday the European Commission has revoked the marketing authorization for generic versions of its multiple sclerosis drug Tecfidera held by the firms Accord, Neuraxpharm, Polpharma and Teva. While the patent for Biogen’s drug has expired in the United States, it had scored a win in Europe in March after the EU’s Court of Justice blocked generic versions of Tecfidera in the region.
Factbox-Electronic Cigarettes the World
The World Health Organization (WHO) has suggested governments treat e-cigarettes, also known as vaporizers, the same as tobacco and ban all flavours. This may cause disruption to some primary tobacco companies, which have staked their long-term stakes on a transition to cigarette opportunities. British American Tobacco, for example, needs 50% of its profits to come from “non-combustible” products by 2035. Vaporizers were banned in 34 countries in July this year, according to the WHO. adding Brazil, India, Iran and Iran. Thailand. But many countries struggle to enforce regulations on e-cigarettes, meaning they must be purchased on the black market. According to the WHO, 74 countries, most of them in Africa but also Pakistan, Colombia and Mongolia, did not regulate e-cigarettes at all as of July. In other countries, including key markets such as the United States and China, governments allow vaporizers but regulate their use. Here’s how they measure up: AUSTRALIA
Aldeyra Therapeutics’ Skin Disease Drug Successfully Completes Midterm Study
Aldeyra Therapeutics said on Tuesday its experimental drug to treat a type of chronic skin disease was safe and well tolerated in a mid-stage study. The drug, ADX-629, also helped reduce the severity of eczema symptoms in adult patients with mild to moderate atopic dermatitis, the Lexington, Massachusetts-based company said.
BioNTech aims to start mRNA vaccine output in Rwanda in 2025
COVID-19 vaccine maker BioNTech aims to start production at its mRNA vaccine factory in Rwanda in 2025, company officials said on Monday, the first production of mRNA vaccines through a foreign company on the continent. The first modular factory elements of the German company, founded in Transport Containers were delivered in March at the Kigali structure and then assembled into so-called BioNTainers.
The U. S. FDA has ruled that the U. S. Food and U. S. Approves First Test to Identify Risk of Opioid Addiction
The U. S. Food and Drug Administration (FDA) announced Tuesday that it has approved the first screening to assess whether there is a risk of opioid addiction in some people. The control, AvertD, is being developed through the personal company SOLVD Health. The FDA granted approval to AutoGenomics, a unit acquired through SOLVD in 2019.
(With agencies. )